ChemicalBook > Product Catalog >Biochemical Engineering >Nucleoside drugs >DMT-2'-F-Bz-dA

DMT-2'-F-Bz-dA

DMT-2'-F-Bz-dA Suppliers list
Company Name: Allbiosyn Biotechnology Co.,Ltd.
Tel: +8618666985712
Email: info@allbiosyn.com
Products Intro: Product Name:5'-O-DMTr-2'-F-dA(Bz)
CAS:136834-21-4
Purity:99.5%HPLC,Single impurity≤0.1% Package:Customized Packaging
Company Name: BOC Sciences
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Products Intro: Product Name:N6-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoroadenosine
CAS:136834-21-4
Purity:98% Remarks:Reach out to us for more information about custom solutions.
Company Name: SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tel: +86-021-61551413 +8618813727289
Email: contact@trustwe.com
Products Intro: Product Name:DMT-2'-F-Bz-dA
CAS:136834-21-4
Company Name: Career Henan Chemica Co
Tel: +86-0371-86658258 +8613203830695
Email: laboratory@coreychem.com
Products Intro: Product Name:Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-
CAS:136834-21-4
Purity:98% HPLC Package:25KG;100USD
Company Name: NINGBOBENKANGJS PHARMTECHCO., LTD
Tel: +8615990591583 15990591583
Email:
Products Intro: Product Name:DMT-2'-F-BZ-DA N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
CAS:136834-21-4
Purity:99% HPLC Package:1g;10g;100g;1kg;5kg

DMT-2'-F-Bz-dA manufacturers

  • DMT-2'-F-Bz-dA
  • DMT-2'-F-Bz-dA pictures
  • $0.00 / 1G
  • 2026-03-30
  • CAS:136834-21-4
  • Min. Order: 1G
  • Purity: 98%
  • Supply Ability: 2000
  • 5'-DMT-2'-F-Bz-dA
  • 5'-DMT-2'-F-Bz-dA pictures
  • $0.00 / 100g
  • 2024-08-08
  • CAS:136834-21-4
  • Min. Order: 100g
  • Purity: ≥98%(HPLC)
  • Supply Ability: 20tons
DMT-2'-F-Bz-dA Basic information
Product Name:DMT-2'-F-Bz-dA
Synonyms:N6-benzoyl-2'-deoxy-2'-fluoro-5'-O-(4,4'-dimethoxytrityl)adenosine;N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroadenosine;Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-;N6-Benzoyl-5'-O-DMT-2'-fluoro-2'-deoxyadenosine;AK-64782;5'-DMT-2'-F-Bz-dA;DMT-2'-F-BZ-DA N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide;5'-O-DMT-N6-Bz-2'-F-dA
CAS:136834-21-4
MF:C38H34FN5O6
MW:675.7
EINECS:
Product Categories:Modified(deoxy)nucleoside
Mol File:136834-21-4.mol
DMT-2'-F-Bz-dA Structure
DMT-2'-F-Bz-dA Chemical Properties
density 1.35±0.1 g/cm3(Predicted)
storage temp. 2-8°C
form Solid
pka7.87±0.43(Predicted)
color White to light yellow
InChIKeyDDOOVEXTSRBCMU-RDDJVILNNA-N
SMILESO=C(C1C=CC=CC=1)NC1N=CN=C2C=1N=CN2[C@H]1[C@H](F)[C@H](O)[C@@H](COC(C2C=CC=CC=2)(C2C=CC(OC)=CC=2)C2C=CC(OC)=CC=2)O1 |&1:18,19,21,23,r|
Safety Information
MSDS Information
DMT-2'-F-Bz-dA Usage And Synthesis
Uses5''-O-DMT-N6-Benzoyl-2''-fluoro-2''-deoxyadenosine (CAS# 136834-21-4) is a nucleoside building block, used in the preparation of 3'',4''-oxetane nucleosides for their anti-viral properties towards Hepatitis C.
Synthesis
4,4'-Dimethoxytrityl chloride

40615-36-9

N6-Benzoyl-2'-Fluoro-2'-deoxyadenosine

136834-20-3

DMT-2'-F-Bz-dA

136834-21-4

N-(9-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide (570 g, 1.53 mol) was dissolved in pyridine (2.85 L, 35.2 mol). The reaction mixture was cooled to 2.6 °C, followed by the addition of 4,4'-bimethoxytrityl chloride (543 g, 1.60 mol). The reaction mixture was stirred at 0 to 5 °C for 2 h and then slowly warmed to room temperature. The progress of the reaction was monitored by LC/MS and after confirming that the reaction was complete, the mixture was cooled below 5°C and the reaction was quenched by slow addition of methanol (124 ml, 3.05 mol) with continuous stirring for 15 min. Subsequently, the reaction mixture was concentrated by co-evaporation with toluene (2.00 L) and diluted with a solvent mixture of ethyl acetate (2.85 L) and n-heptane (2.85 L). The organic layer was washed with 9% saturated aqueous sodium bicarbonate (2.0 L) and ethyl acetate (2.85 L) was added to ensure complete dissolution of the crude product. After stirring for 5 minutes, the organic and aqueous layers were separated. After the organic layer was washed with water (2.0 L), solids began to slowly precipitate out. After separation of the aqueous layer, the organic layer was concentrated to approximately 1/50th of the original volume. the crude product was slurried with a solvent mixture of n-heptane (2.00 L) and toluene (0.50 L), stirred for 15 minutes, and then the light yellow solid was collected by vacuum filtration. The filter cake was washed sequentially with a solvent mixture of (1) n-heptane (0.60 L) and toluene (0.30 L) and (2) n-heptane (3.00 L). The solid was dried at room temperature for 30 min, then transferred to a tray and dried in a vacuum oven at 50 °C overnight to afford the target compound N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide (996.7 g. 1.47 mol, 97% yield).NMR data confirmed the structure of the product.

References[1] Patent: WO2018/152450, 2018, A1. Location in patent: Page/Page column 61; 62
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 15, p. 4539 - 4543
[3] Patent: WO2018/156625, 2018, A1. Location in patent: Paragraph 0290; 0291
[4] Journal of Medicinal Chemistry, 1993, vol. 36, # 7, p. 831 - 841
[5] Tetrahedron Letters, 1998, vol. 39, # 13, p. 1657 - 1660
DMT-2'-F-Bz-dA Preparation Products And Raw materials
Raw materials4,4'-Dimethoxytrityl chloride-->N6-Benzoyl-2'-Fluoro-2'-deoxyadenosine
Tag:DMT-2'-F-Bz-dA(136834-21-4) Related Product Information
Benzoylmetronildazole